226 related articles for article (PubMed ID: 9457397)
1. Renal cell carcinoma and interleukin-2: what are the endpoints?
Figlin RA
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S68-9. PubMed ID: 9457397
[No Abstract] [Full Text] [Related]
2. Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.
NĂ©grier S
J Clin Oncol; 2004 Apr; 22(7):1174-6. PubMed ID: 14981101
[No Abstract] [Full Text] [Related]
3. Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
Figlin RA; Pierce WC; Belldegrun A
Semin Oncol; 1993 Dec; 20(6 Suppl 9):11-5. PubMed ID: 8284686
[No Abstract] [Full Text] [Related]
4. Immunotherapy for metastatic renal cell carcinoma.
McDermott DF; Rini BI
BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
[No Abstract] [Full Text] [Related]
5. [The immunotherapy of advanced renal cell carcinoma].
Bergmann L; Weidmann E; Mitrou PS
Dtsch Med Wochenschr; 1991 Mar; 116(10):384-90. PubMed ID: 1705879
[No Abstract] [Full Text] [Related]
6. Relapse after successful treatment with immunotherapy: lessons for the future.
Fisher RI
Cancer J Sci Am; 1998; 4(2):78-9. PubMed ID: 9532407
[No Abstract] [Full Text] [Related]
7. Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma.
Little B; Young M; Ho KJ
Int J Clin Pract; 2002; 56(1):36-9. PubMed ID: 11831831
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2.
Correale P; Marsili S; Sabatino M; Montagnani F; Giorgi G; Francini G
Oncol Rep; 2005 Apr; 13(4):751-6. PubMed ID: 15756453
[TBL] [Abstract][Full Text] [Related]
9. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
10. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic approaches for renal cancer.
Pizza G; de Vinci C; Viza D
Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
[No Abstract] [Full Text] [Related]
12. Interleukin-2.
Med Lett Drugs Ther; 1987 Sep; 29(749):88-9. PubMed ID: 3306301
[No Abstract] [Full Text] [Related]
13. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects].
Granov AM; Molchanov OE
Vopr Onkol; 2008; 54(4):401-9. PubMed ID: 18942393
[No Abstract] [Full Text] [Related]
14. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M; Gore M; Eisen T
J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
[TBL] [Abstract][Full Text] [Related]
15. Treatment with pentoxifylline and ciprofloxacin reduces the toxicity of high-dose interleukin-2 and lymphokine-activated killer cells.
Thompson JA; Benyunes MC; Bianco JA; Fefer A
Semin Oncol; 1993 Dec; 20(6 Suppl 9):46-51. PubMed ID: 8284692
[No Abstract] [Full Text] [Related]
16. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T
Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
[TBL] [Abstract][Full Text] [Related]
17. Predicting response to interleukin-2 therapy among patients with renal cell carcinoma.
Leppert JT; Lam JS; Belldegrun AS
J Immunother; 2005; 28(5):427-9. PubMed ID: 16113598
[No Abstract] [Full Text] [Related]
18. Sarcomatoid renal cell carcinoma.
Akhtar K; Shamshad A; Sufian Z; Tariq M
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):120-2. PubMed ID: 21196626
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute.
Linehan WM; Walther MM; Alexander RB; Rosenberg SA
Semin Urol; 1993 Feb; 11(1):41-3. PubMed ID: 8465127
[No Abstract] [Full Text] [Related]
20. Systemic therapy of metastatic renal cell carcinoma.
Vugrin D
Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
[No Abstract] [Full Text] [Related]
[Next] [New Search]